High-throughput technologies such as next generation genomics and proteomics are capable of generating massive amounts of data in a relatively cheap manner. With information comes the potential for misinterpretation. In this session several examples will be presented which demonstrate this approach to testing may not only be uninformative, but may also cause harm due to overdiagnosis and overtreatment.